Home/Filings/4/0001127602-24-014265
4//SEC Filing

Klobuchar Michael A 4

Accession 0001127602-24-014265

CIK 0000310158other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 4:06 PM ET

Size

11.6 KB

Accession

0001127602-24-014265

Insider Transaction Report

Form 4
Period: 2024-05-04
Klobuchar Michael A
EVP - Chief Strategy Officer
Transactions
  • Tax Payment

    Common Stock

    2024-05-04$127.51/sh437$55,72223,621.195 total
  • Exercise/Conversion

    Common Stock

    2024-05-04$127.51/sh+887$113,10124,058.195 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-048870 total
    From: 2022-05-04Exp: 2024-05-04Common Stock (887 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    6.292
  • Common Stock - 401(k) Plan

    (indirect: By 401(k))
    866.536
  • Common Stock - 401(k) Plan

    (indirect: By Spouse)
    697.493
  • Common Stock

    (indirect: By Children)
    6.292
Footnotes (4)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F4]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001871957

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:06 PM ET
Size
11.6 KB